GTx strikes deal with UT Research Foundation
Memphis-based GTx Inc. has entered into a license agreement with the University of Tennessee Research Foundation. The agreement will result in GTx developing new therapies that can aid in the treatment of castration-resistant prostate cancer, which were created at the University of Tennessee.